Sales: SEK8.5 billion, a decrease of 2% in Swedish kronas. Organic Sales Development: Decreased by 1%, with M&A adding 6% and currency effects reducing by 7%. EBITA: SEK1,587 million, with a margin of 18.7%. Negative FX Impact: Over SEK100 million. Cash Flow: SEK1 billion. Net Debt: SEK8,937 billion, with a net debt to EBITDA ratio of 1.2%. Return on Capital Employed: 11.6%. Earnings Per Share (EPS): SEK4.31, a decrease of 4% excluding items affecting comparability. Restructuring Costs: SEK80 million for the quarter. CapEx Guidance: Unchanged at SEK1.650 billion for the full year. Restructuring Costs Guidance: Increased to SEK500 million for the full year.

Warning! GuruFocus has detected 2 Warning Sign with WIT.

Release Date: July 17, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

Trelleborg AB (FRA:TLLB) achieved an EBITA margin of 18.7%, nearly a record high for the company. The company successfully executed several acquisitions, including National Gummi in Sweden, Sico in Germany, and Aero-Plastics in North America, which are expected to strengthen its market position. Despite a challenging market, Trelleborg AB (FRA:TLLB) maintained a solid cash flow of SEK1 billion, demonstrating effective working capital management. The company reported positive organic sales growth in its Industrial Solutions segment, driven by strong performance in Marine Solutions and LNG projects. Trelleborg AB (FRA:TLLB) continues to focus on sustainability, achieving significant reductions in carbon dioxide emissions and maintaining a high share of renewable and fossil-free electricity usage.

Negative Points

Trelleborg AB (FRA:TLLB) experienced a 2% decline in sales for the quarter, primarily due to negative currency translation effects. The automotive segment faced a substantial downturn, with double-digit negative organic sales, impacting overall organic growth. The company faced a negative FX impact of over SEK100 million in the quarter. Sealing Solutions reported a 4% decline in organic sales, largely due to the downturn in the automotive sector. The Medical Solutions segment experienced a temporary downturn in North America, leading to negative organic sales growth.

Q & A Highlights

Q: Can you explain the rationale behind reducing the pace of share buybacks by half? Are you planning to change the balance between buybacks and dividends, or should we expect a higher acquisition pace? A: We have reduced the buyback pace compared to last year but maintained the same pace as last quarter. This decision is to ensure room for acquisitions while keeping leverage at a manageable level. We believe the current buyback level is appropriate for now.

Story Continues

Q: Regarding your guidance, when you mention "somewhat higher" demand, does this imply low single-digit organic growth for Q3? Did you observe this trend in June, including the automotive sector? A: Yes, we anticipate solid positive organic growth, potentially in the low single digits. While we haven't seen an improvement in automotive order intake, we expect in-quarter conversion to rise. Other industrial segments are expected to improve based on good Q2 order intake.

Q: How did you manage to keep the Sealing Solutions margin stable despite an unexpected drop in automotive demand? Was it due to a mix effect or operational improvements? A: The stability was primarily due to operational improvements and better efficiency from integrating acquisitions, rather than a mix effect. We continue to enhance our cost and price management, which has helped maintain margins despite lower volumes.

Q: What is missing for Medical Solutions to start showing positive growth, given that organic levels are similar to two years ago? A: We are seeing an increase in new inquiries and quoting levels, indicating positive momentum. The volatility is due to customer purchasing patterns, but we are confident in achieving 5% to 10% growth in the coming years based on current order intake.

Q: With Sealing Solutions' margin trend declining over the past few years, at what point do you consider structural cost adjustments to stabilize margins? A: We have been actively managing costs, including factory closures and manufacturing shifts. While margins have been stable, we need solid organic growth to improve them further. We are confident that with improved volumes, we will achieve better leverage and margin stability.

Q: Can you provide more details on the positive outlook, particularly regarding end markets and geographies? Have you started capacity adjustments in the automotive sector? A: We see improvements across all geographies and segments except automotive. We are making short-term capacity adjustments in automotive but not structural changes. We believe the current downturn is due to inventory reductions, which cannot continue at this pace.

Q: How have tariffs affected your pricing strategy, and are competitors engaging in pricing activities? A: We have adjusted prices to account for tariffs, with minimal impact on our margins. Our regional manufacturing setup has allowed us to benefit in some areas. Overall, the pricing environment remains stable, with no significant issues.

Q: Given the current margin levels, how realistic is it to achieve your margin target by the end of the year? A: Achieving the margin target is feasible with improved volumes in core segments. We believe that with positive organic sales growth, the target is within reach. We remain optimistic about meeting our margin goals by year-end.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

This article first appeared on GuruFocus.